STRS Ohio’s Dianthus Therapeutics DNTH Stock Holding History

STRS Ohio’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$440K	Buy	5,000 +2,700	+117%	+$280K	﹤0.01%	1293
2026 Q2	$224K	Buy	+2,300	New	+$201K	﹤0.01%	1543
2022 Q2	–	Sell	-75	Closed	-$3K	–	2102
2022 Q1	$3K	Hold	75	–	–	﹤0.01%	2121
2021 Q4	$5K	Hold	75	–	–	﹤0.01%	2164
2021 Q3	$8K	Hold	75	–	–	﹤0.01%	2208
2021 Q2	$11K	Hold	75	–	–	﹤0.01%	2197
2021 Q1	$14K	Hold	75	–	–	﹤0.01%	2117
2020 Q4	$9K	Hold	75	–	–	﹤0.01%	2110
2020 Q3	$8K	Hold	75	–	–	﹤0.01%	2139
2020 Q2	$9K	Hold	75	–	–	﹤0.01%	2104
2020 Q1	$7K	Hold	75	–	–	﹤0.01%	1957
2019 Q4	$18K	Hold	75	–	–	﹤0.01%	1982
2019 Q3	$12K	Hold	75	–	–	﹤0.01%	2010
2019 Q2	$17K	Hold	75	–	–	﹤0.01%	2040
2019 Q1	$19K	Hold	75	–	–	﹤0.01%	1970
2018 Q4	$6K	Hold	75	–	–	﹤0.01%	2046
2018 Q3	$14K	Buy	+75	New	+$15.8K	﹤0.01%	2062

Other funds holding DNTH

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Peak Financial Advisors Denver, Colorado $232M AUM 12.16% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

QP Wealth Management Eatontown, New Jersey $66.5M AUM 63.94% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

STRS Ohio's DNTH Position: Q3 2026 in Review

STRS Ohio increased its Dianthus Therapeutics (DNTH) stake by 117% in Q3 2026, buying an estimated $280K and bringing the position to 5,000 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

STRS Ohio first reported a position in DNTH in Q3 2018 and has held it in 17 quarters since. 39 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

STRS Ohio held 5,000 shares of Dianthus Therapeutics worth $440K as of Q3 2026.
STRS Ohio bought 2,700 Dianthus Therapeutics shares in Q3 2026, an estimated $280K.
Dianthus Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1293 holding.
STRS Ohio first reported a position in Dianthus Therapeutics in Q3 2018 and has held it in 17 quarters since.
39 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.